We have detected that you are using Internet Explorer or Microsoft Edge Legacy. Please consider upgrading your browser to any of the following for the best experience.
The need for genetic testing can fluctuate during pregnancy, which is why PreventionGenetics offers multiple testing options and has genetics specialists available to help guide you through your patients’ genetic testing journey to work towards the best possible care for your patients.
In an effort to make genetic testing more accessible, we’re now offering a Patient Prompt Pay (self-pay) discount of 10% if payment is received in full when we receive the test requisition form (TRF).
PreventionGenetics Receives FDA Approval for its Companion Diagnostic Genetic Test as a Class II Medical Device
Published on
PreventionGenetics, a subsidiary of Exact Sciences Corp., announced today that it was recently granted marketing authorization for the POMC/PCSK1/LEPR companion diagnostic (CDx) genetic test as a Class II device by the Center for Devices and Radiological Health (CDRH), a division of the Food and Drug Administration (FDA). Developed in collaboration with Rhythm Pharmaceuticals, Inc., the test is the first FDA-authorized Class II molecular companion diagnostic device.
We recently released an option for our pre-defined panels to be run on a PGnome® (genome) sequencing backbone. But you may be wondering … what’s a backbone?